CCL2 and neoplasm: The main difference between MAFs and primary tumor‐related fibroblasts is that MAFs have a stronger ability to inhibit the anti‐tumor effect of immune cells, which is reflected explicitly in the higher levels of CC motif chemokines ligand 2 (CCL2), CXCL12, and interferon‐related genes secreted by MAFs.139